Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Hinze

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Biochemical Society Transactions|April 22, 2018
Local actin polymerization during endocytic carrier formationClaudia Hinze, Emmanuel Boucrot
Journal of Cell Science|December 4, 2018
Endocytosis in proliferating, quiescent and terminally differentiated cellsClaudia Hinze, Emmanuel Boucrot
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2020
Measuring Endocytosis During Proliferative Cell QuiescenceClaudia Hinze, Kieran McGourty, Emmanuel Boucrot
Discovery Immunology|June 11, 2025
CD28 and TCR differentially impact naïve and memory T cell responsesCayman Williams, Dalisay Giovacchini, Alan Kennedy, et al.
Clinical and Experimental Immunology|March 10, 2026
An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitisNeil Halliday, Alan Kennedy, Cayman Williams, et al.
The EMBO Journal|February 2, 2023
The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80Alan Kennedy, Maximillian A Robinson, Claudia Hinze, et al.
Immunology|May 7, 2021
Regulation of CTLA-4 recycling by LRBA and Rab11Daniel Janman, Claudia Hinze, Alan Kennedy, et al.
Frontiers in Immunology|December 28, 2020
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4Neil Halliday, Cayman Williams, Alan Kennedy, et al.
Cell Reports|September 15, 2024
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interactionMaximillian A Robinson, Alan Kennedy, Carolina T Orozco, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor AgonistsStefan Schunk, Klaus Linz, Sven Frormann, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biochemical Society Transactions|April 22, 2018
Local actin polymerization during endocytic carrier formationClaudia Hinze, Emmanuel Boucrot
Journal of Cell Science|December 4, 2018
Endocytosis in proliferating, quiescent and terminally differentiated cellsClaudia Hinze, Emmanuel Boucrot
Methods in Molecular Biology (Clifton, N.J.)|November 22, 2020
Measuring Endocytosis During Proliferative Cell QuiescenceClaudia Hinze, Kieran McGourty, Emmanuel Boucrot
Discovery Immunology|June 11, 2025
CD28 and TCR differentially impact naïve and memory T cell responsesCayman Williams, Dalisay Giovacchini, Alan Kennedy, et al.
Clinical and Experimental Immunology|March 10, 2026
An imbalance between CD80 and CD86 levels and CD4 regulatory T cell number and transendocytosis function exists in the liver in autoimmune hepatitisNeil Halliday, Alan Kennedy, Cayman Williams, et al.
The EMBO Journal|February 2, 2023
The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80Alan Kennedy, Maximillian A Robinson, Claudia Hinze, et al.
Immunology|May 7, 2021
Regulation of CTLA-4 recycling by LRBA and Rab11Daniel Janman, Claudia Hinze, Alan Kennedy, et al.
Frontiers in Immunology|December 28, 2020
CD86 Is a Selective CD28 Ligand Supporting FoxP3+ Regulatory T Cell Homeostasis in the Presence of High Levels of CTLA-4Neil Halliday, Cayman Williams, Alan Kennedy, et al.
Cell Reports|September 15, 2024
Rigid, bivalent CTLA-4 binding to CD80 is required to disrupt the cis CD80/PD-L1 interactionMaximillian A Robinson, Alan Kennedy, Carolina T Orozco, et al.
ACS Medicinal Chemistry Letters|August 23, 2014
Discovery of Spiro[cyclohexane-dihydropyrano[3,4-b]indole]-amines as Potent NOP and Opioid Receptor AgonistsStefan Schunk, Klaus Linz, Sven Frormann, et al.
Pageof 2